Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -314,925 | -153,040 | -305,250 | -48,359 | -31,428 |
| Depreciation Amortization | 94,802 | 97,531 | 102,317 | 96,813 | 43,460 |
| Income taxes - deferred | 4,324 | -35,133 | 16,092 | -66,300 | -123,536 |
| Accounts receivable | 7,376 | 20,397 | 58,011 | -25,637 | -4,845 |
| Accounts payable and accrued liabilities | 15,636 | -26,083 | 20,171 | -19,819 | -18,122 |
| Other Working Capital | -68,807 | -58,144 | 48,352 | -19,933 | 205,536 |
| Other Operating Activity | 89,072 | 45,331 | -31,773 | 115,281 | 92,959 |
| Operating Cash Flow | $-172,522 | $-109,141 | $-92,080 | $32,046 | $164,024 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -10 | 0 |
| PPE Investments | -12,070 | -26,635 | -39,253 | -17,146 | -10,846 |
| Net Acquisitions | N/A | N/A | N/A | 15,878 | -79,000 |
| Purchase Of Investment | -1,200 | -1,000 | -9,625 | -14,424 | -4,375 |
| Sale Of Investment | N/A | 1,516 | 2,211 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -5,000 | -5,000 |
| Other Investing Activity | 0 | 0 | 0 | -5,000 | -5,000 |
| Investing Cash Flow | $-13,270 | $-26,119 | $-46,667 | $-20,702 | $-99,221 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 294,780 | 26,917 | 92,421 | 22,407 | 261,339 |
| Debt Issued | 200,293 | 55,000 | N/A | N/A | N/A |
| Debt Repayment | -28,800 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 76,059 | 93,674 | 2,132 | 8,576 | 25,921 |
| Other Financing Activity | -367,084 | -34,681 | -33,510 | -66,178 | -254,255 |
| Financing Cash Flow | $175,248 | $140,910 | $61,043 | $-35,195 | $33,005 |
| Exchange Rate Effect | -477 | -676 | 470 | -1,014 | -1,117 |
| Beginning Cash Position | 96,473 | 91,499 | 168,733 | 193,598 | 96,907 |
| End Cash Position | 85,452 | 96,473 | 91,499 | 168,733 | 193,598 |
| Net Cash Flow | $-11,021 | $4,974 | $-77,234 | $-24,865 | $96,691 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,522 | -109,141 | -92,080 | 32,046 | 164,024 |
| Capital Expenditure | -12,741 | -27,858 | -46,524 | -18,547 | -10,846 |
| Free Cash Flow | -185,263 | -136,999 | -138,604 | 13,499 | 153,178 |